Annual Review Course Webcast (2019)
Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
In preparation for the American Board of Urology (ABU) Qualifying (Part 1) Examination, residents need to have basic urologic knowledge to prepare them for the ABU examinations. To fulfill this need, the American Urological Association (AUA) developed this course to disseminate current urologic knowledge. This course is also of interest to practicing urologist preparing for the ABU Knowledge Assessment as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.
Registration Fees
Membership Category |
|
---|---|
Member | $920 |
Non-Member | $1150 |
Member Resident/Allied | $510 |
Non-Member Resident/Allied | $635 |
Target Audience
- Residents
- Urologists
Learning Objectives
At the conclusion of this course, participants will be able to:
- Apply basic, generally accepted urological practices for superior patient care.
- Demonstrate core knowledge of urology necessary for Part I of the American Board of Urology (ABU) qualifying examination and for the ABU Knowledge Assessment.
- Utilize AUA Guidelines for appropriate patient evaluation and management.
ANATOMY AND EMBRYOLOGY
Howard B. Goldman, MD, FACS
- Applied Anatomy
- Embryology
PENILE AND URETHRAL CANCER
Robert G. Uzzo, MD
- Epidemiology
- Diagnosis and Staging
- Imaging and Treatment
BLADDER CANCER
Michael A. O’Donnell, MD
- Epidemiology, Anatomy, Diagnosis and Imaging
- Treatment of NMIBC/ Superficial Disease Managment
- Bladder Cancer Test Questions
Angela M. Smith, MD, MS, FACS
- Staging and Risk Stratification of Muscle Invasive Bladder Cancer
- Multidisciplinary Treatment including Radical Cystectomy, Lymphadenectomy, Peri-Operative Chemotherapy and Chemoradiation Therapy
- Metabolic Derangements that Occur with Diversions
- Other Bladder Sparing Treatments
- Treatment of Metastatic Disease
- Bladder Cancer Test Questions
ERECTILE DYSFUNCTION
John P. Mulhall, MD
- Physiology of Erection, Pathophysiology of Erectile Dysfunction
- Evaluation and Management of Erectile Dysfunction
- Pathophysiology, Evaluation and Management of Priapism Pathophysiology, Evaluation and Management of Peyronie’s Disease
BPH
Claus G. Roehrborn, MD
- Evaluation
- Medical Management
- Surgical Management
RENAL AND URETERAL TUMORS
Robert G. Uzzo, MD
- Epidemiology, Anatomy, Diagnosis and Imaging (Including Evaluation of Renal Masses)
- Treatment of Localized Disease (Including Role of Partial Nephrectomy)
- Treatment of Metastatic Disease
- Transitional Cell Carcinoma
PROSTATE CANCER
Adam S. Kibel, MD
- Diagnosis and Screen, Staging, Imaging (including PSA Screening Controversies)
- Treatment of Localized Cancer (U.S. Stages A and B), Watchful Waiting, Radiation, Interstitial Irradiation, Surgery, Cryosurgery and Hormonal Therapy
- Treatment of Advanced Cancer (U.S. Stages C and D) and Treatment of Radiation Failure
- DVT Prophylaxis
PEDIATRIC UROLOGY
Andrew J. Kirsch, MD
- Congenital Urinary Tract Abnormalities
- UPJ Obstruction, UVJ Obstruction (megaureter)
- Ureteroceles
- Cystic Kidney Disease
- Posterior Urethral Valves
- Prune Belly Syndrome
- Vesicoureteral Reflux
Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
- Pediatric Urinary Incontinence and Bladder Disorders
- Voiding Dysfunction and Neurogenic Bladder
- Developmental Anomalies of the Bladder
- Urinary Tract Infection and Secondary Reflux
- Management of Neurogenic and Non-Neurogenic Bladder
- Pediatric Metabolic Stones
Andrew J. Kirsch, MD
- Disorders of the Genitalia/Scrotum
- Disorders of Sexual Differentiation
- Hypospadias
- Undescended Testicle
Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
- Pediatric Urological Oncology
- Wilms’ Tumor and Other Renal Tumors
- Rhabdomyosarcoma
- Neuroblastoma
- Testis Tumors
Andrew J. Kirsch, MD and Armando J. Lorenzo, MD, MSc, FRCSC, FAAP, FACS
- Pediatric Review Questions
GU RADIOLOGY
Nicole M. Hindman, MD
- Basics of MR, CT, US, VCUG
- Solid and Cystic Renal Masses (CT and MR)
- Transitional Cell Carcinoma
- Prostate MR
- Adrenal Imaging
- Scrotal Imaging
- Retroperitoneal Tumors
- Radiation Basic Principles
URINARY TRACT INFECTION
Michel Y. Pontari, MD
- Urinary Tract Infection
INFECTION AND INFLAMMATION
Daniel A. Shoskes, MD
- Interstitial Cystitis
- Sexually Transmitted Diseases (Gonorrhea, Chlamydia, AIDS and others)
RENAL MEDICINE
Daniel A. Shoskes, MD
- Renal Transplantation
- Renal Vascular Disease
- Renal Physiology (including Fluid and Electrolytes)
ADRENAL
Steven J. Shichman, MD
- Epidemiology, Diagnosis and Imaging (including Cushings, Hyperaldosteronism, Pheochromocytoma, Cancer and the Incidentally Found Adrenal Mass)
- Management (including Pheochromocytoma, Cancer, Hyperaldosteronism, Incidentaloma and Metastatic Disease)
NEUROUROLOGY
Stephen R. Kraus, MD
- Neurourology
URODYNAMICS
Stephen R. Kraus, MD and Howard B. Goldman, MD, FACS
- Urodynamics Tracing Review
FEMALE UROLOGY
Howard B. Goldman, MD, FACS
- Overactive Bladder/Urgency Incontinence
- Stress Urinary Incontinence
- Pelvic Organ Prolapse
- Vaginal Masses/Urethral Diverticulum
- Urinary Fistula
UROLITHIASIS (MEDICAL MANAGEMENT)
Sara L. Best, MD
- Epidemiology, PathophysiologY
- Evaluation and Medical Management
LAPAROSCOPY
Steven J. Shichman, MD
- Physiology and Complications
UROLITHIASIS (SURGICAL MANAGEMENT)
Sara L. Best, MD
- Surgical Management of Stone Disease
TESTICULAR TUMORS
Wade J. Sexton, MD
- Epidemiology, Diagnosis, Staging and Imaging (including the Role of Markers and CIS)
- Treatment of Seminoma
- Treatment of Non-Seminomatous Germ Cell Tumors (including Controversy Regarding Stage A Management, Risk Factors for Recurrence, Algorithms for Stages A,B, and C)
UROLOGIC TRAUMA
Jay Simhan, MD
- Renal and Ureteral Trauma: Evaluation and Management
- Bladder and Urethral Trauma: Evaluation and Management
- Genital Trauma: Evaluation and Management
- Urethral Stricture Disease
INFERTILITY
Paul J. Turek, MD
- Physiology and Pathophysiology of Male Reproduction
- Evaluation of the Infertile Male
- Treatment of the Infertile Male (Surgical and Non-surgical)
- Hypogonadism
- Testosterone Replacement
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity: 26.00 hours
Release Date: June, 2019
Expiration Date: June, 2022
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 26.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Price
AUA Members save 25%! For more information on membership benefits, visit www.AUAnet.org/Join.
Registration Fees
Membership Category |
|
---|---|
Member | $920 |
Non-Member | $1150 |
Member Resident/Allied | $510 |
Non-Member Resident/Allied | $635 |
Webcast will be available to view on Wednesday, June 5, 2019.